A STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND HEMATOPOIETIC STEM CELL MOBILIZATION OF TG-0054 ALONE OR IN COMBINATION WITH G-CSF IN PATIENTS WITH MULTIPLE MYELOMA, NON-HODGKIN LYMPHOMA OR HODGKIN DISEASE: